Company
SetPoint Medical
A revolutionary new treatment for rheumatoid arthritis
Also known as SetPoint Medical Corporation
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Valencia, CA, United States
- Legal name
- SetPoint Medical Corporation
- setpointmedical.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
The convergence of extraordinary advances in immunology, neuroscience, and engineering have resulted in the development of an entirely new treatment approach for rheumatoid arthritis: Neuroimmune Modulation. This device-based therapeutic approach includes a small, wireless, implantable device, the SetPoint System, that stimulates the vagus nerve—activating the body’s innate pathways to reduce inflammation and restore immunologic balance.
Funding snapshot
- Total raised
- $334MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $115M2025-03-27
Funding rounds
- Round, 2025
- $115M2025-03-27, SEC form D sold, 24 investors
- Round, 2023
- $80M2023-01-18, SEC form D sold, 21 investors
- Round, 2020
- $64.4M2020-10-30, SEC form D sold, 26 investors
- Round, 2019
- $15.7M2019-09-04, SEC form D sold, 8 investors
- Round, 2015
- $15.1M2015-08-21, SEC form D sold, 7 investors
- Round, 2013
- $30.6M2013-08-02, SEC form D sold, 7 investors
- Round, 2011
- $3.3M2011-11-07, SEC form D sold, 4 investors
- Round, 2010
- $5M2010-10-06, SEC form D sold, 3 investors
- Round, 2009
- $4M2009-05-14, SEC form D sold, 2 investors
Products
- Hardware
- SetPoint System
Loading relationship preview